Similar articles

• Treatment of systemic lupus erythematosus (SLE) with immunosuppressive drugs 1: An analysis of immunologic data.

  Cruchaud A, Pometta D, Rousso C. Cruchaud A, et al. Helv Med Acta. 1967 Dec;34(1):5-22. Helv Med Acta. 1967. PMID: 4173836 No abstract available.
• [Antinuclear factors. I. Clinical and immuno-pathologic significance].

  Peltier AP. Peltier AP. Presse Med (1893). 1970 Oct 28;78(45):1969-73. Presse Med (1893). 1970. PMID: 4098224 French. No abstract available.
• [Antibodies against native DNA. The methods for their demonstration. Their diagnostic and pathogenetic importance in systemic lupus erythematosus].

  Kostadinova DA, Razboĭnikov S. Kostadinova DA, et al. Vutr Boles. 1976;15(2):18-26. Vutr Boles. 1976. PMID: 59467 Review. Bulgarian. No abstract available.
• Auto-immunity and systemic lupus erythematosus.

  Whaley K. Whaley K. Med Lab Technol. 1972 Apr;29(2):133-42. Med Lab Technol. 1972. PMID: 4116076 Review. No abstract available.
• Bullous pemphigoid associated with systemic lupus erythematosus.

  Jordon RE, Muller SA, Hale WL, Beutner EH. Jordon RE, et al. Arch Dermatol. 1969 Jan;99(1):17-25. Arch Dermatol. 1969. PMID: 4178218 No abstract available.